IMR Press / FBL / Volume 1 / Issue 5 / DOI: 10.2741/A147

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article
Application of sperm antigens in immunocontraception
Show Less
1 Division of Research, Department of Obstetrics and Gynecology, Medical College of Ohio, Toledo, Ohio 43699, USA
Academic Editor:Rajesh K. Naz
Front. Biosci. (Landmark Ed) 1996, 1(5), 87–95; https://doi.org/10.2741/A147
Published: 1 September 1996
(This article belongs to the Special Issue Male reproductive medicine)
Abstract

Development of a vaccine(s) based on sperm antigens represents a promising approach for contraception. The utility of an antigen in immunocontraception is contingent upon its tissue specificity, involvement in human fertility, and immunogenicity. A number of antigens have been characterized from the sperm surface. Notable among these are LDH-C4, RSA antigens, PH-20, SP 1U, HSA-63, FA-1, FA-2 and CS-1. These antigens have been proposed as potential candidates for the development of contraceptive vaccine(s). Their current status, application, relative merits, and immunogenicity in immunocontraception are discussed in this review.

Share
Back to top